Photo credit: MSI
A person looking ahead smiling

The guiding vision behind our Africa teams’ approach is a future where girls have the health, economic opportunity and agency to contribute to a thriving and self-determining Africa. Our work in 2022 has countless examples of the power of a localised approach which values the expertise of local partners and working in partnership with governments to deliver sustainable solutions.

Faustina Fynn-Nyame
Executive Director, Africa
$212million
grants disbursed in 2022
$96 million
Child Health
$83 million
SRHR
$12 million
Girl Capital
$15 million
Climate
$7 million
Cross cutting

An example of our 2022 Girl Capital impact

In 2022, the world’s first Development Impact Bond for adolescent reproductive health in Kenya, In Their Hands (ITH), came to an end after significant success. Launched in partnership with the UK Foreign Commonwealth and Development Office and implemented by Triggerise, the main goal of ITH is to connect adolescent girls to SRH services in Kenya.

A key part of the development of this programme was the mobile platform Tiko, developed by Triggerise. Over 19 months the programme enabled 362,000 visits by Kenyan adolescent girls (148% of its target) and recorded 118,000 repeat visits (262% of its target). This helped to avert an estimated 136,000 unwanted pregnancies. Building on this success, CIFF helped establish an additional $4.7 million outcomes fund, which will continue to support the scale of ITH and support its expansion into public sector facilities in Kenya.

Read more here

A group of people standing together
Photo credit: Triggerise/Alice Oldenburg

An example of our 2022 Resilient Communities impact

doctors with a patient
Photo credit: Sightsavers/David GNAHA

Resilient Communities is a pillar of CIFF’s Africa strategy which brings together our work on health system strengthening, NTDs, WASH, nutrition and climate. 2022 was an important year for NTDs, as it marked the Kigali Summit, where the Kigali declaration was signed reiterating the commitment to the WHO’s 2021-30 roadmap for NTDs.

2022 was also the year that the WHO certified the Democratic Republic of the Congo (DRC) as transmission free of dracunculus medinensis, the parasite which causes Guinea Worm disease. CIFF has been partnering with the Carter Center since 2012 on the eradication of dracunculus medinensis - the DRC marks the sixth country declared transmission free within that period, alongside Cote d’Ivoire, Ghana, Kenya, Niger and Nigeria. To help towards full eradication of this disease, CIFF is extending its support to the Carter Center though to 2025.

Across all our work in NTDs CIFF supported 58 million treatments across seven African countries, and worked with many excellent partners including Sightsavers, Uniting to Combat NTDs, the END Fund, the Carter Center and Orbis.

Download CIFF's 2022 Annual Report here